Involvement of brain‐derived neurotrophic factor in cannabinoid receptor‐dependent protection against excitotoxicity
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Cannabinoid type 1 (CB1) receptors play a central role in the protection against excitotoxicity induced by treatment of mice with kainic acid (KA). As inactivation of CB1 receptor function in mice blocks KA‐induced increase of brain‐derived neurotrophic factor (BDNF) mRNA levels in hippocampus, the notion was put forward that BDNF might be a mediator, at least in part, of CB1 receptor‐dependent neuroprotection [Marsicano et al. (2003) Science, 302, 84–88]. To assess this signalling cascade in more detail, organotypic hippocampal slice cultures were used, as this in vitro system conserves morphological and functional properties of the hippocampus. Here, we show that both genetic ablation of CB1 receptors and pharmacological blockade with the specific CB1 receptor antagonist SR141716A increased the susceptibility of the in vitro cultures to KA‐induced excitotoxicity, leading to extensive neuronal death. Next, we found that the application of SR141716A to hippocampal cultures from wild‐type mice abolished the KA‐induced increase in BDNF protein levels. Therefore, we tried to rescue these organotypic cultures from neuronal death by exogenously applied BDNF. Indeed, BDNF was sufficient to prevent KA‐induced neuronal death after blockade of CB1 receptor signalling. In conclusion, our results strongly suggest that BDNF is a key mediator in CB1 receptor‐dependent protection against excitotoxicity, and further underline the physiological importance of the endogenous cannabinoid system in neuroprotection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394
A simple method for organotypic cultures of nervous tissue
Stoppini, L., Buchs, P.-A., & Muller, D. (1991) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(91)90128-m · Cited by 3,089
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728
Self-citationCB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., Azad, S. C., Cascio, M. G., Gutiérrez, S. O., van der Stelt, M., et al. (2003) · Science · doi:10.1126/science.1088208 · Cited by 1,208
Self-citationBrunet, A., Datta, S. R., & Greenberg, M. E. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00211-7 · Cited by 1,188
Calcium regulation of neuronal gene expression
West, A. E., Chen, W. G., Dalva, M. B., Dolmetsch, R. E., Kornhauser, J. M., Shaywitz, A. J., Takasu, M. A., Tao, X., & Greenberg, M. E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191352298 · Cited by 1,034
Histopathologic Technic and Practical Histochemistry
Melnick, P. J. (1966) · American Journal of Clinical Pathology · doi:10.1093/ajcp/46.3.384 · Cited by 987
An endogenous cannabinoid (2-AG) is neuroprotective after brain injury
Panikashvili, D., Simeonidou, C., Ben-Shabat, S., Hanuš, L., Breuer, A., Mechoulam, R., & Shohami, E. (2001) · Nature · doi:10.1038/35097089 · Cited by 752
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action
Di Marzo, V., Melck, D., Bisogno, T., & De Petrocellis, L. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01283-1 · Cited by 712
Isackson, P. J., Huntsman, M. M., Murray, K. D., & Gall, C. M. (1991) · Neuron · doi:10.1016/0896-6273(91)90234-q · Cited by 711
Kainate, a double agent that generates seizures: two decades of progress
Ben-Ari, Y., & Cossart, R. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01659-3 · Cited by 632
Hetman, M., Kanning, K., Cavanaugh, J. E., & Xia, Z. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22569 · Cited by 575
BDNF Protects the Neonatal Brain from Hypoxic-Ischemic Injury In Vivo via the ERK Pathway
Han, B. H., & Holtzman, D. M. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-15-05775.2000 · Cited by 544
Schauwecker, P. E., & Steward, O. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4103 · Cited by 506
BDNF and epilepsy: too much of a good thing?
Binder, D. K., Croll, S. D., Gall, C. M., & Scharfman, H. E. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01682-9 · Cited by 454
NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults
Cheng, B., & Mattson, M. P. (1994) · Brain Research · doi:10.1016/0006-8993(94)91857-0 · Cited by 396
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis
Pryce, G., Ahmed, Z., Hankey, D. J. R., Jackson, S. J., Croxford, J. L., Pocock, J. M., Ledent, C., Petzold, A., Thompson, A. J., Giovannoni, G., et al. (2003) · Brain · doi:10.1093/brain/awg224 · Cited by 342
Regulation of Extracellular Signal-Regulated Kinase by Cannabinoids in Hippocampus
Derkinderen, P., Valjent, E., Toutant, M., Corvol, J.-C., Enslen, H., Ledent, C., Trzaskos, J., Caboche, J., & Girault, J.-A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02371.2003 · Cited by 331
Croll, S. D., Suri, C., Compton, D. L., Simmons, M. V., Yancopoulos, G. D., Lindsay, R. M., Wiegand, S. J., Rudge, J. S., & Scharfman, H. E. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00296-1 · Cited by 312
The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt
del Pulgar, T. G., Velasco, G., & Guzmán, M. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3470369 · Cited by 259
Cannabinoid Receptor Agonists Protect Cultured Rat Hippocampal Neurons from Excitotoxicity
Shen, M., & Thayer, S. A. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.3.459 · Cited by 250
Franklin, A., Parmentier-Batteur, S., Walter, L., Greenberg, D. A., & Stella, N. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07767.2003 · Cited by 231
Increased Severity of Stroke in CB1 Cannabinoid Receptor Knock-Out Mice
Parmentier-Batteur, S., Jin, K., Mao, X. O., Xie, L., & Greenberg, D. A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09771.2002 · Cited by 225
Anandamide, but not 2‐arachidonoylglycerol, accumulates during in vivo neurodegeneration
Hansen, H. H., Schmid, P. C., Bittigau, P., Lastres‐Becker, I., Berrendero, F., Manzanares, J., Ikonomidou, C., Schmid, H. H. O., Fernández‐Ruiz, J. J., & Hansen, H. S. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00542.x · Cited by 215
BDNF mRNA expression in the developing rat brain following kainic acid-induced seizure activity
Dugich-Djordjevic, M. M., Tocco, G., Willoughby, D. A., Najm, I., Pasinetti, G., Thompson, R. F., Baudry, M., Lapchak, P. A., & Hefti, F. (1992) · Neuron · doi:10.1016/0896-6273(92)90133-x · Cited by 214
(2002) · PubMed · Cited by 192
Veldhuis, W. B., van der Stelt, M., Wadman, M. W., van Zadelhoff, G., Maccarrone, M., Fezza, F., Veldink, G. A., Vliegenthart, J. F. G., Bär, P. R., Nicolay, K., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-10-04127.2003 · Cited by 179
Molecular biology of cannabinoid receptors
Lutz, B. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0342 · Cited by 167
Self-citationRudge, J. S., Mather, P. E., Pasnikowski, E. M., Cai, N., Corcoran, T. L., Acheson, A. L., Anderson, K., Lindsay, R. M., & Wiegand, S. J. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6737 · Cited by 159
Acute Neuronal Injury, Excitotoxicity, and the Endocannabinoid System
van der Stelt, M., Veldhuis, W. B., Maccarrone, M., Bär, P. R., Nicolay, K., Veldink, G. A., Marzo, V. D., & Vliegenthart, J. F. G. (2002) · Molecular Neurobiology · doi:10.1385/mn:26:2-3:317 · Cited by 154
Kristensen, B. W., Noraberg, J., & Zimmer, J. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02900-6 · Cited by 146
Abood, M. E., Rizvi, G., Sallapudi, N., & McAllister, S. D. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02065-1 · Cited by 127
An Acid-Treatment Method for the Enhanced Detection of GDNF in Biological Samples
Okragly, A. J., & Haak‐Frendscho, M. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6500 · Cited by 116
Larmet, Y., Reibel, S., Carnahan, J., Nawa, H., Marescaux, C., & Depaulis, A. (1995) · NeuroReport · doi:10.1097/00001756-199510020-00027 · Cited by 115
The Role of Brain-derived Neurotrophic Factor in Transient Forebrain Ischemia in the Rat Brain
Tsukahara, T., Yonekawa, Y., Tanaka, K., Ohara, O., Watanabe, S., Kimura, T., Nishijima, T., & Taniguchi, T. (1994) · Neurosurgery · doi:10.1227/00006123-199402000-00016 · Cited by 111
Cheng, A., Wang, S., Yang, D., Xiao, R.-P., & Mattson, M. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207232200 · Cited by 99
Ischemic Brain Damage in Mice after Selectively Modifying BDNF or NT4 Gene Expression
Endres, M., Fan, G., Hirt, L., Fujii, M., Matsushita, K., Liu, X., Jaenisch, R., & Moskowitz, M. A. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200001000-00018 · Cited by 89
Pardridge, W. M. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0123-7_15 · Cited by 88
Role of Bcl‐2 in the Brain‐derived Neurotrophic Factor Survival Response
Allsopp, T. E., Kiselev, S., Wyatt, S., & Davies, A. M. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb01116.x · Cited by 87
Gratacòs, E., Pérez‐Navarro, E., Tolosa, E., Arenas, E., & Alberch, J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00538.x · Cited by 83
Pringle, A. K., Sundström, L., Wilde, G. J. C., Williams, L. R., & lannotti, F. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12745-2 · Cited by 67
Liu, W., Liu, R., Chun, J. T., Bi, R., Hoe, W., Schreiber, S. S., & Baudry, M. (2001) · Brain Research · doi:10.1016/s0006-8993(01)03006-2 · Cited by 67
Hansen, H. S., Moesgaard, B., Hansen, H. H., Schousboe, A., & Petersen, G. (1999) · Lipids · doi:10.1007/bf02562333 · Cited by 50
Mishra, O. P., Akhter, W., Ashraf, Q. M., & Delivoria‐Papadopoulos, M. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00166-0 · Cited by 35
Cited by
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
“…was suggested to protect against excitotoxicity by various mechanisms, including inhibition of calcium channels and stimulation of potassium channels to decrease neuronal excitability and the activation of extracellular signal regulated kinases (Marsicano et al., 2003; Khaspekov et al., 2004).”
BackgroundZou, S., & Kumar, U. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030833 · Cited by 1,343
Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies
Hamilton, J. P., Siemer, M., & Gotlib, I. H. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.57 · Cited by 497
Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?
Hillard, C. J. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.130 · Cited by 445
Heyman, E., Gamelin, F.-X., Goekint, M., Piscitelli, F., Roelands, B., Leclair, E., Di Marzo, V., & Meeusen, R. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.09.017 · Cited by 427
“Moreover, BDNF was shown to be a key mediator of endocannabinoid-induced neuroprotection against other types of acute stress, such as glutamate excitotoxicity (Khaspekov et al., 2004).”
Metadata
- Authors
- Khaspekov, L. G., Brenz Verca, M. S., Frumkina, L. E., Hermann, H., Marsicano, G., & Lutz, B.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2004-04
- Volume
- 19
- Issue
- 7
- Pages
- 1691-1698
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W2031111076
- Cited by
- 184
- References
- 45
- FWCI
- 6.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.